Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

GNC Recognizes Anatabloc® as a Top Vendor of 2012



              GNC Recognizes Anatabloc® as a Top Vendor of 2012

PR Newswire

GLEN ALLEN, Va., March 21, 2013

GLEN ALLEN, Va., March 21, 2013 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ:
STSI) today announced that the Company's dietary supplement, Anatabloc®, was
selected as a recipient of the annual GNC Top Vendor Awards.  Specifically,
Anatabloc® was recognized by GNC as the Wellness Winner in the category of
Best Product Innovation for 2012.  The award recipients were announced via
GNC's social media outlets and were recognized at the 2013 Arnold Sports
Festival in Columbus, Ohio, in February.

(Photo: http://photos.prnewswire.com/prnh/20130321/PH81026 )
(Photo: http://photos.prnewswire.com/prnh/20110830/PH59627 )
(Logo: http://photos.prnewswire.com/prnh/20130319/PH79245LOGO )

Anatabloc® was chosen to receive the award based on several criteria,
including: success in bringing a product into a mature, competitive category;
success in establishing the product with effective marketing, sampling, and
trial drivers; and success in becoming a best-selling new product.

"We could not ask for a better partner than GNC," stated David Dean, Vice
President of Sales and Marketing for Star Scientific, Inc. "The growth of
Anatabloc® and increase in awareness of the product over the past year could
not have happened without the support of GNC.  We are honored to have been
chosen for this award."

Tom Dowd, Executive Vice President, Chief Merchandising Officer & General
Manager of GNC, stated, "Sales of Anatabloc® continue to surpass our
expectations.  We are proud to recognize Star Scientific and Anatabloc® with
the 2012 GNC Top Vendor Award for Best Product Innovation in the Wellness
category."

Recently, the Company increased the number of lozenges/tablets in both
Anatabloc® and Anatabloc® Unflavored from 200 to 300, an increase of 50% over
the former quantity.  This change was made after researchers for the Company
developed a new recommended usage of the products based on body weight.  The
weight classification and usage recommendation chart is now displayed on
Anatabloc® packaging and on the Anatabloc® website (www.anatabloc.com).  The
transition from the 200-count to the 300-count bottle will be complete in all
GNC stores during the month of April.

Also, the Company is pleased to announce that the Anatabloc® Rare Cellular
Facial Creme is now available for sale on GNC's website (www.GNC.com) and on
the Anatabloc® website (www.anatabloc.com).  A related Anatabloc® facial
cleanser and serum are in development.

Certain statements contained in this release constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act
of 1995. Such statements include, but are not limited to statements identified
by words such as "believes," "expects," "anticipates," "estimates," "intends,"
"plans," "targets," "projects" and similar expressions. The statements in this
release are based upon the current beliefs and expectations of our company's
management and are subject to significant risks and uncertainties. Actual
results may differ from those set forth in the forward-looking statements.
Numerous factors could cause or contribute to such differences, including, but
not limited to, results of clinical trials and/or other studies, the
challenges inherent in new product development initiatives, including the
continued development and market acceptance of our nutraceutical dietary
supplements products, the effect of any competitive products, our ability to
license and protect our intellectual property, our ability to raise additional
capital in the future that is necessary to maintain our business, changes in
government policy and/or regulation, potential litigation by or against us and
any governmental review of our products or practices, as well as other risks
discussed from time to time in our filings with the Securities and Exchange
Commission, including, without limitation, our annual report on Form 10-K for
the fiscal year ended December 31, 2012. We undertake no duty to update any
forward-looking statement or any information contained in this press release
or in other public disclosures at any time.

About Star Scientific
Star Scientific, Inc. is a technology-oriented company with a mission to
promote maintenance of a healthy metabolism and lifestyle. Through its wholly
owned subsidiary, Rock Creek Pharmaceuticals, Star Scientific has been engaged
in the manufacturing, sale, and marketing of two nutraceutical dietary
supplements, a cosmetic facial cream, and the development of other
nutraceuticals and pharmaceuticals. The company also continues to pursue the
licensing of the technology behind its proprietary StarCured® curing process
and its related products. Rock Creek Pharmaceuticals has scientific and
research offices in Gloucester, MA, and a regulatory office in Washington, DC.
Star Scientific has a Corporate and Sales Office in Glen Allen, VA, and an
Executive, Scientific & Regulatory Affairs office in Washington, DC.

Contact:
Talhia T. Tuck
Vice President, Communications and Investor Relations
Star Scientific, Inc.
(202)887-5100
ttuck@starscientific.com

SOURCE Star Scientific, Inc.

Website: http://www.anatabloc.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement